Cargando…

Type 1 diabetes can present before the age of 6 months and is characterised by autoimmunity and rapid loss of beta cells

AIMS/HYPOTHESIS: Diabetes diagnosed at <6 months of age is usually monogenic. However, 10–15% of affected infants do not have a pathogenic variant in one of the 26 known neonatal diabetes genes. We characterised infants diagnosed at <6 months of age without a pathogenic variant to assess wheth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johnson, Matthew B., Patel, Kashyap A., De Franco, Elisa, Hagopian, William, Killian, Michael, McDonald, Timothy J., Tree, Timothy I. M., Domingo-Vila, Clara, Hudson, Michelle, Hammersley, Suzanne, Dobbs, Rebecca, Ellard, Sian, Flanagan, Sarah E., Hattersley, Andrew T., Oram, Richard A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641942/ https://www.ncbi.nlm.nih.gov/pubmed/33029656 http://dx.doi.org/10.1007/s00125-020-05276-4

Ejemplares similares

Congenital beta cell defects are not associated with markers of islet autoimmunity, even in the context of high genetic risk for type 1 diabetes
por: Wyatt, Rebecca C., et al.
Publicado: (2022)

A type 1 diabetes genetic risk score can discriminate monogenic autoimmunity with diabetes from early-onset clustering of polygenic autoimmunity with diabetes
por: Johnson, Matthew B., et al.
Publicado: (2018)

Syndromic monogenic diabetes genes should be tested in patients with a clinical suspicion of MODY
por: Colclough, Kevin, et al.
Publicado: (2022)

Exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1β-associated renal disease and can be symptomatic
por: Clissold, Rhian L, et al.
Publicado: (2018)

Comment on: Khurana et al. The Diagnosis of Neonatal Diabetes in a Mother at 25 Years of Age. Diabetes Care 2012;35:e59
por: Chakera, Ali J., et al.
Publicado: (2013)

Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism
por: Kapoor, Ritika R, et al.
Publicado: (2013)

Screening for neonatal diabetes at day 5 of life using dried blood spot glucose measurement
por: McDonald, Timothy J., et al.
Publicado: (2017)

Patterns of postmeal insulin secretion in individuals with sulfonylurea-treated KCNJ11 neonatal diabetes show predominance of non-K(ATP)-channel pathways
por: Bowman, Pamela, et al.
Publicado: (2019)

A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin
por: Shepherd, Maggie H., et al.
Publicado: (2018)

Persistent C‐peptide is associated with reduced hypoglycaemia but not HbA(1c) in adults with longstanding Type 1 diabetes: evidence for lack of intensive treatment in UK clinical practice?
por: Marren, S. M., et al.
Publicado: (2019)

Clinical and molecular characterisation of hyperinsulinaemic hypoglycaemia in infants born small-for-gestational age
por: Arya, Ved Bhushan, et al.
Publicado: (2013)

Neurogenin 3 is important but not essential for pancreatic islet development in humans
por: Rubio-Cabezas, Oscar, et al.
Publicado: (2014)

RET gene mutations are not a common cause of congenital solitary functioning kidney in adults
por: Oram, Richard A., et al.
Publicado: (2009)

Beta cell function and ongoing autoimmunity in long-standing, childhood onset type 1 diabetes
por: Williams, Georgina M., et al.
Publicado: (2016)

Urinary C-Peptide Creatinine Ratio Is a Practical Outpatient Tool for Identifying Hepatocyte Nuclear Factor 1-α/Hepatocyte Nuclear Factor 4-α Maturity-Onset Diabetes of the Young From Long-Duration Type 1 Diabetes
por: Besser, Rachel E.J., et al.
Publicado: (2011)

GATA6 Mutations Cause a Broad Phenotypic Spectrum of Diabetes From Pancreatic Agenesis to Adult-Onset Diabetes Without Exocrine Insufficiency
por: De Franco, Elisa, et al.
Publicado: (2013)

Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease
por: Flanagan, Sarah E., et al.
Publicado: (2014)

The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells
por: Oram, Richard A., et al.
Publicado: (2013)

Erratum to: The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells
por: Oram, Richard A., et al.
Publicado: (2013)

PLIN1 Haploinsufficiency Is Not Associated With Lipodystrophy
por: Laver, Thomas W, et al.
Publicado: (2018)

Mutations of the Same Conserved Glutamate Residue in NBD2 of the Sulfonylurea Receptor 1 Subunit of the K(ATP) Channel Can Result in Either Hyperinsulinism or Neonatal Diabetes
por: Männikkö, Roope, et al.
Publicado: (2011)

Neonatal diabetes caused by a homozygous KCNJ11 mutation demonstrates that tiny changes in ATP sensitivity markedly affect diabetes risk
por: Vedovato, Natascia, et al.
Publicado: (2016)

Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes
por: Babiker, Tarig, et al.
Publicado: (2016)

Incretin hormone responses to carbohydrate and protein/fat are preserved in adults with sulfonylurea‐treated KCNJ11 neonatal diabetes
por: Bowman, Pamela, et al.
Publicado: (2023)

Diazoxide-unresponsive congenital hyperinsulinism associated with ABCC8 nonsense mutation
por: Hussain, Suhaimi, et al.
Publicado: (2015)

Allelic drop-out may occur with a primer binding site polymorphism for the commonly used RFLP assay for the -1131T>C polymorphism of the Apolipoprotein AV gene
por: Ward, Kirsten J, et al.
Publicado: (2006)

Erratum. Recessively Inherited LRBA Mutations Cause Autoimmunity Presenting as Neonatal Diabetes. Diabetes 2017;66:2316–2322
por: Johnson, Matthew B., et al.
Publicado: (2018)

Assessment of the HNF1B Score as a Tool to Select Patients for HNF1B Genetic Testing
por: Clissold, Rhian, et al.
Publicado: (2015)

Monitoring islet specific immune responses in type 1 diabetes clinical immunotherapy trials
por: Arif, Sefina, et al.
Publicado: (2023)

Biallelic RFX6 mutations can cause childhood as well as neonatal onset diabetes mellitus
por: Sansbury, Francis H, et al.
Publicado: (2015)

The HNF4A R76W mutation causes atypical dominant Fanconi syndrome in addition to a β cell phenotype
por: Hamilton, Alexander J, et al.
Publicado: (2014)

High-Sensitivity CRP Discriminates HNF1A-MODY From Other Subtypes of Diabetes
por: McDonald, Tim J., et al.
Publicado: (2011)

The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study
por: De Franco, Elisa, et al.
Publicado: (2015)

Evaluation of Evidence for Pathogenicity Demonstrates That BLK, KLF11, and PAX4 Should Not Be Included in Diagnostic Testing for MODY
por: Laver, Thomas W., et al.
Publicado: (2022)

Macrosomia and Hyperinsulinaemic Hypoglycaemia in Patients with Heterozygous Mutations in the HNF4A Gene
por: Pearson, Ewan R, et al.
Publicado: (2007)

Clinical and Genetic Characteristics, Management and Long-Term Follow-Up of Turkish Patients with Congenital Hyperinsulinism
por: Güven, Ayla, et al.
Publicado: (2016)

Diabetes Susceptibility in the Canadian Oji-Cree Population Is Moderated by Abnormal mRNA Processing of HNF1A G319S Transcripts
por: Harries, Lorna W., et al.
Publicado: (2008)

Neonatal diabetes in Wolcott–Rallison syndrome: a case report
por: Ngoc, Can Thi Bich, et al.
Publicado: (2013)

Homozygous Mutations in NEUROD1 Are Responsible for a Novel Syndrome of Permanent Neonatal Diabetes and Neurological Abnormalities
por: Rubio-Cabezas, Oscar, et al.
Publicado: (2010)

South Asian individuals with diabetes who are referred for MODY testing in the UK have a lower mutation pick-up rate than white European people
por: Misra, Shivani, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_45vbjk5qb4eb75lj03li2fqkon